9月24日晚间公告 | 精智达交付首台存储器高速测试机；皖维高新预计前三季度净利润增长超69.81%

Mergers and Acquisitions - Dalong Real Estate's controlling subsidiary plans to acquire 60% equity of Beijing Chengzhu Real Estate Development Co., Ltd [1] Share Buybacks - China Jushi intends to repurchase 30 million to 40 million shares of its own stock [2] - Newpoint Software plans to repurchase shares worth 30 million to 50 million yuan [2] Investment Cooperation and Operational Status - Jingzhida has delivered its first high-speed testing machine to key domestic clients, primarily used in semiconductor memory testing [3] - Tasly Pharmaceutical's subsidiary has received approval for clinical trials of TSL2109 capsule, with no similar dual-target drugs currently in clinical trials domestically or internationally [3] - Shangwei New Materials' affiliated company Zhiyuan Hengyue plans to make a tender offer to acquire 37% of shares at a price of 7.78 yuan per share [3] - Changying Precision has delivered humanoid robot structural components valued over 80 million yuan, with over 400 part numbers supplied to clients [3] - Heng Rui Medicine has signed a licensing agreement for the project of Rykon Trastuzumab, eligible for milestone payments up to 1.093 billion USD [4] - Jiao Cheng Ultrasound is advancing the development and promotion of new products like advanced ultrasound scanning microscopes and ultrasonic bonding machines, successfully obtaining formal orders from well-known domestic clients [4] Performance Changes - Wanwei High-tech expects net profit attributable to shareholders to be between 340 million and 420 million yuan for the first three quarters of 2025, representing a year-on-year increase of 69.81% to 109.77% [5]